Suppr超能文献

[同种异体糖尿病大鼠脂肪间充质干细胞移植治疗糖尿病大鼠创面的初步评价及机制]

[Preliminary evaluation and mechanism of adipose-derived stem cell transplantation from allogenic diabetic rats in the treatment of diabetic rat wounds].

作者信息

Dong J Y, Gong J H, Ji X Y, Tian M, Liu Y K, Qing C, Lu S L, Song F

机构信息

Wound Repair Center, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200025, China.

Department of Orthopaedics, United Family Healthcare, Shanghai 200336, China.

出版信息

Zhonghua Shao Shang Za Zhi. 2019 Sep 20;35(9):645-654. doi: 10.3760/cma.j.issn.1009-2587.2019.09.002.

Abstract

To investigate whether adipose-derived stem cells (ASCs) from allogeneic diabetic rats can promote wound healing in diabetic rats or not and the mechanism. (1) Fifty-six male Wistar rats aged 12-16 weeks were divided into diabetic group and healthy group according to the random number table (the same grouping method below), with 28 rats in each group. Rats in healthy group were not treated with any treatment. Rats in diabetic group were injected with 10 g/L streptozotocin 60 mg/kg intraperitoneally in one time to establish the diabetic model. Four rats in diabetic group and 4 rats in healthy group were selected according to the random number table, and the adipose tissue in the inguinal region was taken to culture and purify ASCs, so as to obtain healthy rat-derived ASCs (hereinafter referred to as nASCs) and diabetic rat-derived ASCs (hereinafter referred to as dASCs). The third passage of nASCs (=3) and dASCs (=3) were taken, and the positive expression rates of cell surface differentiation antigens CD105, CD31, CD34, and CD44 were detected with flow cytometer for defining ASCs purity. (2) The rest 24 rats in healthy group and 24 rats in diabetic group were used to make three round full-thickness skin defect wounds with a diameter of 12 mm on the back of each rat. Immediately after injury, phosphate buffer saline (PBS), nASCs of 2×10(7)/mL, and dASCs of 2×10(7)/mL each in the volume of 0.5 mL were subcutaneously injected into three wounds and their margins of each rat, respectively. On post injury day (PID) 1, 3, 7, and 12, 6 rats in each group were selected according to the random number table to calculate the wound area, and the wound tissue was stained with hematoxylin-eosin to observe the histological morphology of the wound. (3) Human ASCs (hASCs) were subcultured, and the 4th to 7th passage of cells were used for the subsequent experiments. The hASCs were divided into 7 groups, with 12 samples in each group. Cells in blank control group were cultured with mesenchymal stem cell culture medium, and cells in simple advanced glycation end products (AGEs) group, simple protein group, simple high glucose group, simple high osmotic pressure group, AGEs-high glucose combination group, and protein-high osmotic pressure combination group were cultured with mesenchymal stem cell culture medium containing a final mass concentration of 100 mg/L AGEs, 100 mg/L bovine serum albumin (BSA), 28 mmol/L D-glucose, 28 mmol/L mannitol, 100 mg/L AGEs+ 28 mmol/L D-glucose, 100 mg/L BSA+ 28 mmol/L mannitol, respectively. Cell proliferation was detected by cell counting kit 8 at post culture hour (PCH) 2 and on post culture day (PCD) 2, 4 and 6. (4) The hASCs were divided into blank control group, simple AGE group, simple high glucose group, and AGE-high glucose combination group, with 12 samples in each group, which were treated the same as corresponding groups in experiment (3). On PCD 0, 2, 4, and 6, the positive expression rates of cell surface differentiation antigens CD105, CD44, and CD45 were detected by flow cytometer to estimate their homeostasis. (5) The hASCs were divided into AGE-high glucose combination group and protein-high osmotic pressure combination group, with 9 samples in each group, which were treated the same as corresponding groups in experiment (3). On PCD 2, 4, and 6, the expression of intracellular protein was detected by cyanine 3-streptavidin double-antibody sandwich technique. Data were processed with analysis of variance for factorial design, least significant difference test, and Bonferroni correction. (1) The positive expression rates of CD44 in nASCs and dASCs were both higher than 96%, the positive expression rates of CD31 and CD34 were low, and the positive expression rates of CD105 were about 40%, which basically met the purity requirements. (2) The areas of wounds treated by three methods in rats of healthy group and diabetic group were similar on PID 1 (>0.05). In healthy group, compared with (0.682 1±0.078 9), (0.314 3±0.113 7), and (0.064 3±0.002 1) cm(2) of the PBS-treated wounds in rats, the area of nASCs-treated wounds in rats decreased significantly on PID 3, 7, and 12 [(0.464 1±0.092 6), (0.223 9±0.072 7), and (0.034 3±0.012 5) cm(2), <0.05], the area of dASCs-treated wounds in rats decreased significantly on PID 3 and 12 [(0.514 1±0.124 1) and (0.043 7±0.032 8) cm(2), <0.05] but was not obviously changed on PID 7 [(0.274 2±0.062 5) cm(2), >0.05]. Compared with those of the dASCs-treated wounds of rats within the same group, the area of the nASCs-treated wounds of rats in healthy group decreased significantly on PID 3 and 7 (<0.05) but was not obviously changed on PID 12 (>0.05). In diabetic group, compared with (0.853 5±0.204 8), (0.670 5±0.164 8), and (0.131 4±0.074 4) cm(2) of the PBS-treated wounds in rats, the area of nASCs-treated wounds in rats decreased significantly on PID 3, 7, and 12 [(0.633 4±0.132 5), (0.331 8±0.023 5), and (0.074 2±0.003 8) cm(2), <0.05], the area of dASCs-treated wounds in rats decreased significantly on PID 3 [(0.773 6±0.182 2) cm(2), <0.05] but was not obviously changed on PID 7 and 12 [(0.510 6±0.192 2) and (0.114 4±0.003 1) cm(2), >0.05]. Compared with the dASCs-treated wounds of rats within the same group, the area of the nASCs-treated wounds of rats in diabetic group was not obviously changed on PID 3 and 7 (>0.05) but decreased significantly on PID 12 (<0.05). There was no obvious difference in histological morphology of the wounds treated with three methods in rats of each group on PID 1. On PID 3, a small amount of microvessels were formed in the wounds treated with nASCs and dASCs of rats in both groups, but microvessel formation was almost undetected in the PBS-treated wounds. On PID 7, more small blood vessels and fibroblasts (Fbs) were observed in the wounds treated with nASCs and dASCs of rats in both groups, but the small blood vessels and Fbs were slightly less in the PBS-treated wounds. On PID 12, the wounds treated with nASCs and dASCs of rats in the two groups were covered by epithelial tissue, the granulation tissue in the PBS-treated wounds of rats in healthy group was not obvious, and the PBS-treated wounds of rats in diabetic group were not completely epithelialized. (3) Compared with those of blank control group, the cell number of hASCs in simple AGEs group decreased significantly on PCD 2, 4, and 6 (<0.05), which increased significantly on PCD 2 and 4 in simple high glucose group (<0.05), and that in AGEs-high glucose combination group decreased significantly on PCD 4 and 6 (<0.05). (4) Compared with that on PCD 4 within the same group, the positive expression rate of CD105 in hASCs decreased significantly in blank control group, simple AGEs group, and AGEs-high glucose combination group on PCD 6 (<0.05). The positive expression rate of CD44 was higher than 95%, and that of CD45 was less than 2% in hASCs of each group at each time point. (5) Detection values of 7 proteins were located in the confidence interval. The expression levels of basic fibroblast growth factor and tissue inhibitor of metalloproteinase-1 in hASCs of AGEs-high glucose combination group and protein-high osmotic pressure combination group showed increasing trend with the prolongation of culture time. The expression level of human monocyte chemoattractant protein 1 (MCP-1) in hASCs of AGEs-high glucose combination group showed increasing trend with the prolongation of culture time, while the expression level of growth-regulated oncogene (GRO) on PCD 6 was significantly higher than that on PCD 4 within the same group (<0.05); the expression levels of MCP-1 and GRO in hASCs of protein-high osmotic pressure combination group showed decreasing trend with the prolongation of culture time. The expression level of follistatin in hASCs of protein-high osmotic pressure combination group decreased obviously on PCD 4, while that in hASCs of AGEs-high glucose combination group was significantly lower on PCD 6 than that on PCD 4 (<0.05). The expression level of vascular endothelial growth factor (VEGF) in hASCs of protein-high osmotic pressure combination group decreased gradually with the prolongation of culture time, while that in hASCs of AGEs-high glucose combination group on PCD 4 decreased significantly as compared with that on PCD 2 (<0.05). The expression level of urokinase-type plasminogen activator receptor in hASCs of protein-high osmotic pressure combination group on PCD 6 was significantly higher than that on PCD 4 within the same group (<0.05) and that of AGEs-high glucose combination group on PCD 6 (<0.05). Both nASCs and dASCs can promote wound healing in rats with simple defect injury, but dASCs have no significant effect on wound healing in rats with diabetes mellitus, which may be related to the inhibition of ASCs proliferation and the influence of high glucose and AGEs intervention on their homeostasis and secretory function.

摘要

探讨异体糖尿病大鼠脂肪来源干细胞(ASCs)能否促进糖尿病大鼠伤口愈合及其机制。(1)将56只12 - 16周龄雄性Wistar大鼠按随机数字表法分为糖尿病组和健康组(以下分组方法相同),每组28只。健康组大鼠不做任何处理。糖尿病组大鼠一次性腹腔注射10 g/L链脲佐菌素60 mg/kg建立糖尿病模型。按随机数字表法从糖尿病组和健康组中各选取4只大鼠,取腹股沟区脂肪组织培养并纯化ASCs,从而获得健康大鼠来源的ASCs(以下简称nASCs)和糖尿病大鼠来源的ASCs(以下简称dASCs)。取nASCs第3代(P3)和dASCs第3代(P3),用流式细胞仪检测细胞表面分化抗原CD105、CD31、CD34和CD44的阳性表达率以确定ASCs纯度。(2)将健康组剩余的24只大鼠和糖尿病组剩余的24只大鼠,在每只大鼠背部制作3个直径为12 mm的全层皮肤缺损伤口。造伤后立即分别于每个大鼠的3个伤口及其边缘皮下注射0.5 mL磷酸盐缓冲液(PBS)、2×10⁷/mL的nASCs和2×10⁷/mL的dASCs。在伤后第1、3、7和12天,按随机数字表法从每组中选取6只大鼠计算伤口面积,取伤口组织进行苏木精 - 伊红染色观察伤口组织学形态。(3)对人ASCs(hASCs)进行传代培养,取第4至7代细胞用于后续实验。将hASCs分为7组,每组12个样本。空白对照组细胞用间充质干细胞培养基培养,单纯晚期糖基化终末产物(AGEs)组、单纯蛋白组、单纯高糖组、单纯高渗组、AGEs - 高糖联合组和蛋白 - 高渗联合组细胞用终质量浓度为100 mg/L AGEs、100 mg/L牛血清白蛋白(BSA)、28 mmol/L D - 葡萄糖、28 mmol/L甘露醇、100 mg/L AGEs + 28 mmol/L D - 葡萄糖、100 mg/L BSA + 28 mmol/L甘露醇的间充质干细胞培养基培养。在培养后第2小时(PCH 2)以及培养后第2、4和6天用细胞计数试剂盒8检测细胞增殖情况。(4)将hASCs分为空白对照组、单纯AGE组(应为单纯AGEs组)、单纯高糖组和AGEs - 高糖联合组,每组12个样本,处理方法同实验(3)中的相应组。在培养后第0、2、4和6天,用流式细胞仪检测细胞表面分化抗原CD105、CD44和CD45的阳性表达率以评估其稳态。(5)将hASCs分为AGEs - 高糖联合组和蛋白 - 高渗联合组,每组9个样本,处理方法同实验(3)中的相应组。在培养后第2、4和6天,用菁ocyanine 3 - 链霉亲和素双抗体夹心技术检测细胞内蛋白表达。数据采用析因设计方差分析、最小显著差检验和Bonferroni校正进行处理。(1)nASCs和dASCs中CD44的阳性表达率均高于96%,CD31和CD34的阳性表达率较低,CD105的阳性表达率约为40%,基本符合纯度要求。(2)健康组和糖尿病组大鼠中,3种处理方法在伤后第1天的伤口面积相似(>0.05)。在健康组,与大鼠PBS处理伤口的面积(0.682 1±0.078 9)、(0.314 3±0.113 7)和(0.064 3±0.002 1)cm²相比,大鼠nASCs处理伤口在伤后第3、7和12天面积显著减小[(0.464 1±0.092 6)、(0.223 9±0.072 7)和(0.034 3±0.012 5)cm²,<0.05],大鼠dASCs处理伤口在伤后第3和12天面积显著减小[(0.514 1±0.124 1)和(0.043 7±0.032 8)cm²,<0.05],但在伤后第7天无明显变化[(0.274 2±0.062 5)cm²,>0.05]。与同组大鼠dASCs处理伤口相比,健康组大鼠nASCs处理伤口在伤后第3和7天面积显著减小(<0.05),但在伤后第12天无明显变化(>0.05)。在糖尿病组,与大鼠PBS处理伤口的面积(0.853 5±0.204 8)、(0.670 5±0.164 8)和(0.131 4±0.074 4)cm²相比,大鼠nASCs处理伤口在伤后第3、7和12天面积显著减小[(0.633 4±0.132 5)、(0.331 8±0.023 5)和(0.074 2±0.003 8)cm²,<0.05],大鼠dASCs处理伤口在伤后第3天面积显著减小[(0.773 6±0.182 2)cm²,<0.05],但在伤后第7和12天无明显变化[(0.510 6±0.192 2)和(0.114 4±0.003 1)cm²,>0.05]。与同组大鼠dASCs处理伤口相比,糖尿病组大鼠nASCs处理伤口在伤后第3和7天无明显变化(>0.05),但在伤后第12天面积显著减小(<0.05)。每组大鼠中3种处理方法在伤后第1天的伤口组织学形态无明显差异。在伤后第3天,两组大鼠nASCs和dASCs处理的伤口均有少量微血管形成,但PBS处理的伤口几乎未检测到微血管形成。在伤后第7天,两组大鼠nASCs和dASCs处理的伤口观察到更多小血管和成纤维细胞(Fbs),但PBS处理的伤口中小血管和Fbs略少。在伤后第12天,两组大鼠nASCs和dASCs处理的伤口被上皮组织覆盖,健康组大鼠PBS处理伤口的肉芽组织不明显,糖尿病组大鼠PBS处理伤口未完全上皮化。(3)与空白对照组相比,单纯AGEs组hASCs在培养后第2、4和6天细胞数量显著减少(<0.05),单纯高糖组在培养后第2和4天细胞数量显著增加(<0.05),AGEs - 高糖联合组在培养后第4和6天细胞数量显著减少(<0.05)。(4)与同组培养后第4天相比,空白对照组、单纯AGEs组和AGEs - 高糖联合组hASCs在培养后第6天CD105阳性表达率显著降低(<0.05)。每组hASCs在各时间点CD44阳性表达率均高于95%,CD45阳性表达率均低于2%。(5)7种蛋白检测值均在可信区间内。AGEs - 高糖联合组和蛋白 - 高渗联合组hASCs中碱性成纤维细胞生长因子和金属蛋白酶组织抑制剂 - 1的表达水平随培养时间延长呈上升趋势。AGEs - 高糖联合组hASCs中人单核细胞趋化蛋白1(MCP - 1)的表达水平随培养时间延长呈上升趋势,而生长调节致癌基因(GRO)在培养后第6天的表达水平显著高于同组培养后第4天(<0.05);蛋白 - 高渗联合组hASCs中MCP - 1和GRO的表达水平随培养时间延长呈下降趋势。蛋白 - 高渗联合组hASCs中卵泡抑素在培养后第4天表达明显降低,而AGEs - 高糖联合组hASCs中卵泡抑素在培养后第6天显著低于培养后第4天(<0.05)。蛋白 - 高渗联合组hASCs中血管内皮生长因子(VEGF)的表达水平随培养时间延长逐渐降低,而AGEs - 高糖联合组hASCs中VEGF在培养后第4天较培养后第2天显著降低(<0.05)。蛋白 - 高渗联合组hASCs中尿激酶型纤溶酶原激活剂受体在培养后第6天的表达水平显著高于同组培养后第4天(<0.05)以及AGEs - 高糖联合组培养后第6天(<0.05)。nASCs和dASCs均可促进单纯缺损损伤大鼠的伤口愈合,但dASCs对糖尿病大鼠的伤口愈合无显著作用,这可能与ASCs增殖受抑制以及高糖和AGEs干预对其稳态和分泌功能的影响有关。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验